Ultra-Early Combination Antiplatelet Therapy with Cilostazol for the Prevention of Branch Atheromatous Disease: A Multicenter Prospective Study

201623 citationsJournal Articlegold Open Access

Authors

Teruo Kimura

Adam Tucker · Osaka Medical and Pharmaceutical University

Abstract

Our trial showed that clinical progression of BAD was significantly reduced with the administration of ultra-early aggressive combination therapy using cilostazol compared to treatment with antiplatelet monotherapy.

Topics & Keywords

Antiplatelet Therapy and Cardiovascular Diseases Acute Ischemic Stroke Management Cerebrovascular and Carotid Artery Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cerebrovascular Diseases Extra

Volume 6, Issue 3, pp. 84-95

DOI: 10.1159/000450835

Field-Weighted Citation Impact: 1.35